Tim K Tsang1, Kyu Han Lee2, Betsy Foxman2, Angel Balmaseda3,4, Lionel Gresh3, Nery Sanchez3, Sergio Ojeda3, Roger Lopez3,4, Yang Yang1,5, Guillermina Kuan6, Aubree Gordon2. 1. Department of Biostatistics, University of Florida, Gainesville, Florida, USA. 2. Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA. 3. Sustainable Sciences Institute, Managua, Nicaragua. 4. Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua, Nicaragua. 5. Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA. 6. Centro de Salud Sócrates Flores Vivas, Ministry of Health, Managua, Nicaragua.
Abstract
BACKGROUND: Previous studies suggest that the nose/throat microbiome may play an important role in shaping host immunity and modifying the risk of respiratory infection. Our aim is to quantify the association between the nose/throat microbiome and susceptibility to influenza virus infection. METHODS: In this household transmission study, index cases with confirmed influenza virus infection and their household contacts were followed for 9-12 days to identify secondary influenza infections. Respiratory swabs were collected at enrollment to identify and quantify bacterial species via high-performance sequencing. Data were analyzed by an individual hazard-based transmission model that was adjusted for age, vaccination, and household size. RESULTS: We recruited 115 index cases with influenza A(H3N2) or B infection and 436 household contacts. We estimated that a 10-fold increase in the abundance in Streptococcus spp. and Prevotella salivae was associated with 48% (95% credible interval [CrI], 9-69%) and 25% (95% CrI, 0.5-42%) lower susceptibility to influenza A(H3N2) infection, respectively. In contrast, for influenza B infection, a 10-fold increase in the abundance in Streptococcus vestibularis and Prevotella spp. was associated with 63% (95% CrI, 17-83%) lower and 83% (95% CrI, 15-210%) higher susceptibility, respectively. CONCLUSIONS: Susceptibility to influenza infection is associated with the nose/throat microbiome at the time of exposure. The effects of oligotypes on susceptibility differ between influenza A(H3N2) and B viruses. Our results suggest that microbiome may be a useful predictor of susceptibility, with the implication that microbiome could be modulated to reduce influenza infection risk, should these associations be causal.
BACKGROUND: Previous studies suggest that the nose/throat microbiome may play an important role in shaping host immunity and modifying the risk of respiratory infection. Our aim is to quantify the association between the nose/throat microbiome and susceptibility to influenza virus infection. METHODS: In this household transmission study, index cases with confirmed influenza virus infection and their household contacts were followed for 9-12 days to identify secondary influenza infections. Respiratory swabs were collected at enrollment to identify and quantify bacterial species via high-performance sequencing. Data were analyzed by an individual hazard-based transmission model that was adjusted for age, vaccination, and household size. RESULTS: We recruited 115 index cases with influenza A(H3N2) or B infection and 436 household contacts. We estimated that a 10-fold increase in the abundance in Streptococcus spp. and Prevotella salivae was associated with 48% (95% credible interval [CrI], 9-69%) and 25% (95% CrI, 0.5-42%) lower susceptibility to influenza A(H3N2) infection, respectively. In contrast, for influenza B infection, a 10-fold increase in the abundance in Streptococcus vestibularis and Prevotella spp. was associated with 63% (95% CrI, 17-83%) lower and 83% (95% CrI, 15-210%) higher susceptibility, respectively. CONCLUSIONS: Susceptibility to influenza infection is associated with the nose/throat microbiome at the time of exposure. The effects of oligotypes on susceptibility differ between influenza A(H3N2) and B viruses. Our results suggest that microbiome may be a useful predictor of susceptibility, with the implication that microbiome could be modulated to reduce influenza infection risk, should these associations be causal.
Authors: James J Kozich; Sarah L Westcott; Nielson T Baxter; Sarah K Highlander; Patrick D Schloss Journal: Appl Environ Microbiol Date: 2013-06-21 Impact factor: 4.792
Authors: Takeshi Ichinohe; Iris K Pang; Yosuke Kumamoto; David R Peaper; John H Ho; Thomas S Murray; Akiko Iwasaki Journal: Proc Natl Acad Sci U S A Date: 2011-03-14 Impact factor: 11.205
Authors: Jens W Levy; Benjamin J Cowling; James M Simmerman; Sonja J Olsen; Vicky J Fang; Piyarat Suntarattiwong; Richard G Jarman; Brendan Klick; Tawee Chotipitayasunondh Journal: Am J Epidemiol Date: 2013-04-28 Impact factor: 4.897
Authors: Cuiling Xu; Kwok-Hung Chan; Tim K Tsang; Vicky J Fang; Rita O P Fung; Dennis K M Ip; Simon Cauchemez; Gabriel M Leung; J S Malik Peiris; Benjamin J Cowling Journal: Am J Epidemiol Date: 2015-09-22 Impact factor: 4.897
Authors: A Danielle Iuliano; Katherine M Roguski; Howard H Chang; David J Muscatello; Rakhee Palekar; Stefano Tempia; Cheryl Cohen; Jon Michael Gran; Dena Schanzer; Benjamin J Cowling; Peng Wu; Jan Kyncl; Li Wei Ang; Minah Park; Monika Redlberger-Fritz; Hongjie Yu; Laura Espenhain; Anand Krishnan; Gideon Emukule; Liselotte van Asten; Susana Pereira da Silva; Suchunya Aungkulanon; Udo Buchholz; Marc-Alain Widdowson; Joseph S Bresee Journal: Lancet Date: 2017-12-14 Impact factor: 79.321
Authors: Simon Cauchemez; Christl A Donnelly; Carrie Reed; Azra C Ghani; Christophe Fraser; Charlotte K Kent; Lyn Finelli; Neil M Ferguson Journal: N Engl J Med Date: 2009-12-31 Impact factor: 91.245
Authors: David Groeger; Elisa Schiavi; Ray Grant; Magdalena Kurnik-Łucka; David Michalovich; Rick Williamson; Soren Beinke; Barry Kiely; Cezmi A Akdis; Edith M Hessel; Fergus Shanahan; Liam O' Mahony Journal: EBioMedicine Date: 2020-09-11 Impact factor: 8.143